Sometimes, but not automatically. A packaging change can leave the supplement formula untouched while still requiring a documented packaging assessment, updated specifications, label review, compatibility or stability evidence, and quality-control approval before release.
The right level of work depends on what changes, what the new package contacts, and whether it could affect product quality or required labeling.
What counts as a supplement packaging change?
Packaging is more than artwork. A change may involve the bottle resin, pouch film, cap, liner, seal, desiccant, light barrier, oxygen barrier, container size, serving count, label dimensions, or the way the product is filled and held.
If the new component touches the product or changes its protection from moisture, oxygen, light, contamination, or handling, treat it as a quality decision. Even a larger bottle can change headspace and moisture exposure. A different closure can change seal performance. A smaller label can force regulatory information into a new layout.
FDA’s dietary supplement CGMP framework requires packaging and label specifications, controls for packaging and labeling operations, representative examination of finished packaged product, and quality-control release. That means “same formula” does not equal “no review.”
Can the formula stay the same when packaging changes?
Yes. If the ingredients, quantities, serving size, manufacturing process, and product specifications remain unchanged, the master formula may not need reformulation. However, documentation must still reflect the approved package and label.
FDA’s CGMP compliance guide explains that a master manufacturing record includes a packaging description and representative label. It also requires packaging and labels to be examined against that record before use.
The practical distinction is:
- Reformulation changes what the product is.
- Repackaging changes how the product is contained or presented.
- Relabeling changes the information or claims presented.
- A packaging project can include one, two, or all three.
For a stock product, start with the applicable format, such as CPack’s stock capsules or stock powders. For a custom product, the package should be evaluated alongside the dosage form and formula rather than chosen as a last-minute decoration.
When might a packaging change require testing?
Testing may be appropriate when the new package could change protection, shelf-life support, product contact, sealing, or filling performance. The answer should be risk-based and product-specific.
Retesting is not a universal yes-or-no rule. The change-control record should explain why existing evidence is sufficient or why new evidence is needed.
For hygroscopic powders, gummies, softgels, liquids, and light-sensitive ingredients, package protection can be especially consequential. A format change may also require different filling equipment or line settings. Those process effects should be assessed even when the ingredient formula is unchanged
Does a new label require a full product retest?
Not necessarily, but the label still needs controlled review. The FDA’s dietary supplement labeling guide identifies required statements including the statement of identity, net quantity, Supplement Facts, ingredient list, and the name and place of business of the manufacturer, packer, or distributor.
A redesign can introduce errors without changing the formula. Common risks include:
- The serving size no longer matches the Supplement Facts panel.
- The net quantity is wrong for the new count or package.
- Mandatory information becomes too small or is placed incorrectly.
- Ingredient or allergen information is lost during copy transfer.
- Claims are added that the substantiation file does not support.
- Old artwork remains in circulation and is applied to the wrong lot.
The quality system should control label issuance, use, reconciliation where required, obsolete versions, and final approval. FDA also requires representative examination of repackaged or relabeled batches and quality-control approval before distribution.
What should a brand review before approving new packaging?
Use a documented checklist that connects marketing, operations, regulatory review, and quality:
- Define every component that changes, including material, supplier, dimensions, and specification.
- Confirm whether the package directly contacts the supplement.
- Compare moisture, oxygen, light, and physical protection with the current system.
- Review compatibility with the dosage form and expected storage conditions.
- Confirm the filling line, closure application, coding, label application, and case pack.
- Update the master manufacturing record, packaging specifications, bill of materials, and approved artwork.
- Decide whether existing stability data remain applicable.
- Define incoming checks, in-process checks, and finished-package examination.
- Quarantine and dispose of obsolete components as required by procedure.
- Obtain quality-control approval before distribution.
Approve the change only after the evidence, specifications, records, and operational plan tell the same story. A lower component price can disappear quickly if the change creates line downtime, damaged product, relabeling, or delayed release.
How should you plan a packaging change with a contract manufacturer?
Bring the manufacturer into the decision before artwork and components are ordered. Provide the current package specification, proposed component drawings or data sheets, product format, serving count, desired shelf-life position, storage statement, projected order quantity, and target changeover date.
The manufacturer’s review should clarify component sourcing, minimum order implications, tooling or line compatibility, testing scope, documentation changes, and lead-time dependencies. CPack’s contact page is the appropriate starting point for a project-specific discussion.
For custom products, packaging belongs in the development brief along with formula status, dosage form, quantity, and timing. CPack offers manufacturing paths for formats including custom capsules, custom powders, and custom liquid filling. The relevant package and verification plan can differ across those formats.
Frequently Asked Questions
Possibly, after the new bottle, closure, label, line setup, and documentation are evaluated. Product-contact compatibility, barrier protection, headspace, seal performance, and existing stability support may affect the decision.
Not by itself. The ingredients may stay the same, but the barrier system, handling, filling process, and stability rationale can change enough to require additional assessment or testing.
Only when a qualified review concludes that the data remain applicable. A materially different container-closure system may protect the product differently, so the rationale should be documented rather than assumed.
Label changes should follow the company’s controlled approval process. Required statements, Supplement Facts, ingredients, claims, net quantity, and the correct version for the batch all need review.
Send the current and proposed component specifications, product and formula status, dosage form, serving count, artwork, quantity, shelf-life expectations, storage conditions, and target timing. Flag every change instead of describing the project only as a redesign.
